logo

For the Inventor, By the Inventor

Osaka, Japan

Osaka Bioscience Institute


USPTO Granted Patents = 19

% Expired Patents = 57.9



Forward Citations = 73

Loading Chart...
Loading Chart...

52 inventors (with patents filed for the assignee):

goldMedal Shigekazu Nagata (10 out of 23 patents)

silverMedal Yoshihiro Urade (5 out of 16 patents)

bronzeMedal Norio Nakamura (4 out of 43 patents)

4.  Naomi Eguchi (4 out of 6 patents)

5.  Takashi Suda (3 out of 5 patents)

6.  Naoto Itoh (3 out of 3 patents)

7.  Shin Yonehara (3 out of 3 patents)

8.  Tomohiro Takahashi (2 out of 63 patents)

9.  Maximiliano Vasquez (2 out of 69 patents)

10.  Kamon Shirakawa (2 out of 24 patents)

11.  Yasuyoshi Watanabe (2 out of 21 patents)

12.  Hiroshi Oda (2 out of 23 patents)

13.  Nobuyuki Sato (2 out of 14 patents)

14.  Kosuke Aritake (2 out of 3 patents)

15.  Tomokazu Matsusue (2 out of 5 patents)


19 patents:

1. 8658390 - Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases (2014-02-25),
2. 7760925 - Method for automatically detecting degenerated regions in stained thin section slides (2010-07-20),
3. 7622554 - FAS ligand derived polypeptides (2009-11-24),
4. 7399596 - Method for predicting pregnancy-induced hypertension (2008-07-15),
5. 7314727 - Methods to facilitate diagnosis of normal pressure hydrocephalus (2008-01-01),
6. 7238718 - Method for treating myolytic disease and method for screening antimyolytic agent (2007-07-03),
7. 7202394 - Animal with the mass expression of human gene and test method by using the animal (2007-04-10),
8. 7128905 - Method of treating graft versus host disease by administration of a Fas antagonist (2006-10-31),
9. 6953847 - Fas antigen derivative (2005-10-11),
10. 6949360 - DNA coding for human cell surface antigen (2005-09-27),
11. 6905815 - Method of screening for inhibitors of VCP binding to polyglutamine, abeta, alpha-synuclein, and sod1 (2005-06-14),
12. 6897295 - Antibodies and fragments thereof to Fas ligand and Fas ligand derived polypeptides (2005-05-24),
13. 6884819 - Neuropathy remedies (2005-04-26),
14. 6270998 - DNA coding for human cell surface antigen (2001-08-07),
15. 6114507 - Anti-Fas ligand antibody and assay method using the anti-Fas ligand (2000-09-05),
Company Overview
Osaka Bioscience Institute is a research organization based in Osaka, Japan, dedicated to advancing the fields of biotechnology and life sciences. The institute focuses on innovative research and development in areas such as regenerative medicine, drug discovery, and molecular biology. By fostering collaboration among scientists and industry partners, the institute aims to translate scientific discoveries into practical applications that can improve health outcomes and contribute to the global scientific community.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

19 Patents

#335 in Osaka

#3,037 in Japan

#32,623 in the World

Osaka, JP
Osaka, Japan

Osaka Bioscience Institute

Forward Citations = 73

52 inventors:

goldMedal Shigekazu Nagata (10 out of 23 patents)

silverMedal Yoshihiro Urade (5 out of 16 patents)

bronzeMedal Norio Nakamura (4 out of 43 patents)

4.  Naomi Eguchi (4 out of 6 patents)

5.  Takashi Suda (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Osaka Bioscience Institute. Retrieved from https://idiyas.com/company/osaka-bioscience-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…